Oxycodone Hydrochloride Wockhardt Uk

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycodone Hydrochloride Wockhardt Uk (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxycodone Hydrochloride Wockhardt Uk, is an opioid analgesic presented as a unknown strength/unknown form for oral use. It treats moderate to severe acute pain and chronic pain requiring opioid therapy in adult patients. GNH India supplies Oxycodone Hydrochloride Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Wockhardt Uk Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone Hydrochloride is an opioid analgesic that acts on the central nervous system to manage pain.

Acute postoperative pain: Provides effective relief when non‑opioid analgesics are insufficient.
Cancer‑related pain: Helps control moderate to severe pain associated with malignancy.
Chronic non‑cancer pain: Used when long‑term opioid therapy is deemed appropriate by a clinician.
Traumatic injury pain: Alleviates severe pain following major injuries.

How It Works

Oxycodone Hydrochloride binds selectively to mu‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor activation also produces sedation and can modulate emotional responses to painful stimuli.

Side Effects

Oxycodone Hydrochloride may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects

Constipation: Reduced gastrointestinal motility leading to hard stools.
Nausea: Sensation of queasiness, often accompanied by vomiting.
Drowsiness: Generalized sleepiness or reduced alertness.
Dry mouth: Decreased salivation causing oral discomfort.
Dizziness: Light‑headed feeling, especially when standing quickly.
Itching: Mild pruritus without rash.

Serious or Rare Side Effects

Respiratory depression: Slowed breathing that can be fatal.
Severe hypotension: Markedly low blood pressure causing fainting.
Seizures: Uncontrolled convulsive episodes.
Allergic reactions: Rash, swelling, or anaphylaxis.
Dependence and withdrawal: Physical and psychological reliance with withdrawal symptoms on abrupt cessation.
Cardiac arrhythmias: Irregular heart rhythms that may require medical attention.

Precautions & Warnings

When prescribing Oxycodone Hydrochloride, clinicians should evaluate patient history and monitor for adverse effects.

Assess pain severity: Confirm that opioid therapy is appropriate for the level of pain.
Review medical history: Identify respiratory disorders, head injury, or substance‑use disorder.
Monitor for sedation: Advise patients not to operate machinery or drive while impaired.
Avoid concurrent CNS depressants: Limit use of alcohol, benzodiazepines, or other opioids.
Educate on dependence risk: Discuss signs of tolerance, dependence, and proper discontinuation.
Store at below 25°C: Keep in the original container, protect from moisture and light.

Avoid Interactions

Oxycodone Hydrochloride can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

Benzodiazepines: Combined use can cause profound respiratory depression.
CNS depressants: Alcohol, barbiturates, or other sedatives increase sedation and overdose risk.
MAO inhibitors: May precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely)

CYP3A4 inhibitors: Ketoconazole, erythromycin, and similar agents can raise oxycodone levels.
CYP2D6 inhibitors: Fluoxetine, paroxetine, and quinidine may reduce conversion to active metabolites.
Anticholinergics: May exacerbate constipation and urinary retention.
Diuretics: Can enhance hypotensive effects when combined with opioid‑induced vasodilation.

Frequently Asked Questions

Oxycodone Hydrochloride Wockhardt Uk is an opioid analgesic prescribed for the management of moderate to severe acute pain, such as post‑surgical pain, and for chronic pain conditions where opioid therapy is considered appropriate by a qualified prescriber.

Oxycodone hydrochloride acts as an agonist at mu‑opioid receptors in the central nervous system. By activating these receptors, it inhibits the transmission of pain signals and alters the brain’s perception of pain, providing both analgesia and a degree of sedation.

The appropriate dose of oxycodone hydrochloride is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, age, renal and hepatic function, and other individual factors. Dosage regimens are individualized and should follow local prescribing guidelines.

Safety data for oxycodone use in pregnancy and lactation are limited. Opioids may cause neonatal withdrawal syndrome and can cross the placenta. Use during pregnancy or breastfeeding should only occur when the potential benefit outweighs the risk and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oxycodone is a potent, semi‑synthetic opioid that provides strong analgesia comparable to morphine but with a slightly higher oral bioavailability. Compared with weaker opioids such as codeine, oxycodone offers more reliable pain control for moderate to severe pain, though it also carries a higher risk of dependence and respiratory depression.

Store Oxycodone Hydrochloride tablets at temperatures below 25 °C in their original packaging, protected from moisture, heat and direct sunlight. Do not store in bathrooms or other humid environments.

The medication is taken orally, usually as a tablet, and should be swallowed whole with water unless otherwise directed by a healthcare professional. Dosing intervals are based on the prescribed regimen and the patient’s response to therapy.

The most serious risks include respiratory depression, severe hypotension, profound sedation, dependence, and the potential for overdose. Patients should be educated on recognizing early signs of respiratory compromise and instructed to seek immediate medical attention if they occur.

Oxycodone should be avoided in individuals with known hypersensitivity to the drug, severe respiratory depression, acute or severe asthma, paralytic ileus, or a history of significant substance‑use disorder unless closely monitored by a specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.